|
|
Volumn 55, Issue SUPPL., 2002, Pages
|
|
Analysis of a [14C]-labelled platinum anticancer compound in dosing formulations and urine using a combination of HPLC-ICPMS and flow scintillation counting
|
|
Author keywords
Column liquid chromatography; Inductively coupled plasma mass spectrometry; Platinum anticancer drugs; ZD0473
|
|
Indexed keywords
AMMINEDICHLORO(2 METHYLPYRIDINE)PLATINUM;
ANTINEOPLASTIC AGENT;
CARBON 14;
DRUG METABOLITE;
PLATINUM DERIVATIVE;
ANALYTIC METHOD;
ANIMAL EXPERIMENT;
CONFERENCE PAPER;
CONTROLLED STUDY;
DOG;
DRUG DETERMINATION;
DRUG DOSAGE FORM;
DRUG FORMULATION;
DRUG PURITY;
DRUG URINE LEVEL;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
ISOTOPE LABELING;
MALE;
MASS SPECTROMETRY;
NONHUMAN;
PRIORITY JOURNAL;
SCINTILLATION COUNTING;
URINALYSIS;
|
|
EID: 0036100413
PISSN: 00095893
EISSN: None
Source Type: Journal
DOI: 10.1007/bf02493372 Document Type: Conference Paper |
|
Times cited : (21)
|
|
References (12)
|
